UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

Journal of clinical microbiology, 2018-11, Vol.56 (11)

2018

Volltextzugriff (PDF)

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel

Journal of clinical microbiology, 2017-12, Vol.55 (12), p.3544-3551

2017

Volltextzugriff (PDF)

Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas

Oral oncology, 2014-09, Vol.50 (9), p.771-779

Westra, William H

2014

Volltextzugriff (PDF)

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

Journal of clinical virology, 2018-11, Vol.108, p.32-37

2018

Volltextzugriff (PDF)

Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen)

Molecular biology reports, 2024-12, Vol.51 (1), p.52-52, Article 52

2024

Volltextzugriff (PDF)

Comparison of Aptima and hybrid capture‐2 HPV tests and Pap test in the referral population in Japan

Journal of medical virology, 2021-08, Vol.93 (8), p.5076-5083

2021

Volltextzugriff (PDF)

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30 years

European journal of cancer (1990), 2015, Vol.51 (11), p.1456-1466

2015

Volltextzugriff (PDF)

Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program

International journal of cancer, 2012-03, Vol.130 (5), p.1128-1135

2012

Volltextzugriff (PDF)

The Hybrid Capture 2 Results in Correlation with the Pap Test, Sexual Behavior, and Characteristics of Romanian Women

International journal of environmental research and public health, 2023-02, Vol.20 (5), p.3839

2023

Volltextzugriff (PDF)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

International journal of molecular sciences, 2018-09, Vol.19 (9), p.2704

2018

Volltextzugriff (PDF)

Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection

International journal of cancer, 2015-04, Vol.136 (7), p.1665-1671

2015

Volltextzugriff (PDF)

Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan

Journal of medical virology, 2018-05, Vol.90 (5), p.972-980

2018

Volltextzugriff (PDF)

Agreement between careHPV and hybrid capture 2 in detecting high‐risk HPV in women in Tanzania

Acta obstetricia et gynecologica Scandinavica, 2021-04, Vol.100 (4), p.786-793

2021

Volltextzugriff (PDF)

Comparative community outreach to increase cervical cancer screening in the Mississippi Delta

Preventive medicine, 2011-06, Vol.52 (6), p.452-455

2011

Volltextzugriff (PDF)

Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens

American journal of clinical pathology, 2014-07, Vol.142 (1), p.43-50

2014

Volltextzugriff (PDF)

Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women

The oncologist (Dayton, Ohio), 2016-07, Vol.21 (7), p.825-831

2016

Volltextzugriff (PDF)

Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers

Journal of medical virology, 2016-07, Vol.88 (7), p.1271-1278

2016

Volltextzugriff (PDF)

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening

Journal of lower genital tract disease, 2017-01, Vol.21 (1), p.12-16

2017

Volltextzugriff (PDF)

Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA

Gynecologic oncology, 2011-01, Vol.120 (1), p.89-93

2011

Volltextzugriff (PDF)

Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data

Microbiology spectrum, 2022-02, Vol.10 (1), p.e0157021-e0157021

2022

Volltextzugriff (PDF)

The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck

Diagnostic cytopathology, 2014-01, Vol.42 (1), p.85-93

2014

Volltextzugriff (PDF)

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma

Cancer cell international, 2016-07, Vol.16 (1), p.54-54, Article 54

2016

Volltextzugriff (PDF)

Detection of high-risk human papillomaviruses in fresh breast cancer samples using the hybrid capture 2 assay

Journal of medical virology, 2013-12, Vol.85 (12), p.2087-2092

2013

Volltextzugriff (PDF)

HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India

Cancer causes & control, 2016-03, Vol.27 (3), p.351-358

2016

Volltextzugriff (PDF)

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay

Oral oncology, 2014-06, Vol.50 (6), p.600-604

2014

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Humans
(94)
Life Sciences & Biomedicine
(93)
Hybrid Capture 2
(88)
Female
(85)
Human Papillomavirus
(76)
Adult
(62)
Middle Aged
(57)
Papillomavirus Infections - Diagnosis
(55)
Uterine Cervical Neoplasms - Diagnosis
(49)
Papillomaviridae - Isolation & Purification
(47)
Cervical Cancer
(42)
Sensitivity And Specificity
(38)
Uterine Cervical Neoplasms - Virology
(37)
Cervical Intraepithelial Neoplasia - Virology
(32)
Papillomavirus Infections - Virology
(32)
Cervical Intraepithelial Neoplasia - Diagnosis
(31)
Oncology
(31)
Vaginal Smears
(31)
Aged
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel

Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

Comparison of high-risk HPV detection by the AmpFire® HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen)

Comparison of Aptima and hybrid capture‐2 HPV tests and Pap test in the referral population in Japan

A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30 years

Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program

The Hybrid Capture 2 Results in Correlation with the Pap Test, Sexual Behavior, and Characteristics of Romanian Women

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection

Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan

Agreement between careHPV and hybrid capture 2 in detecting high‐risk HPV in women in Tanzania

Comparative community outreach to increase cervical cancer screening in the Mississippi Delta

Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens

Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women

Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening

Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA

Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data

The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma

Detection of high-risk human papillomaviruses in fresh breast cancer samples using the hybrid capture 2 assay

HPV detection-based cervical cancer screening program in low-resource setting: lessons learnt from a community-based demonstration project in India

Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay

Suchergebnisse filtern